Janssen Tabs Start-Up Scholar Rock For New Immunology Approach
This article was originally published in The Pink Sheet Daily
Executive Summary
The J&J subsidiary has signed a deal with Boston-area Scholar Rock to discover new biologics that aim for a more pinpoint solution to inflammatory disease.